NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus

Clinical trials of BAFF blockade with belimumab have shown partial efficacy for the treatment of systemic lupus erythematosus (SLE), so other therapeutic options are required. Here, the authors present a new small molecule inhibitor that targets NIK with a similar efficacy to BAFF inhibition in two...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hans D. Brightbill, Eric Suto, Nicole Blaquiere, Nandhini Ramamoorthi, Swathi Sujatha-Bhaskar, Emily B. Gogol, Georgette M. Castanedo, Benjamin T. Jackson, Youngsu C. Kwon, Susan Haller, Justin Lesch, Karin Bents, Christine Everett, Pawan Bir Kohli, Sandra Linge, Laura Christian, Kathy Barrett, Allan Jaochico, Leonid M. Berezhkovskiy, Peter W. Fan, Zora Modrusan, Kelli Veliz, Michael J. Townsend, Jason DeVoss, Adam R. Johnson, Robert Godemann, Wyne P. Lee, Cary D. Austin, Brent S. McKenzie, Jason A. Hackney, James J. Crawford, Steven T. Staben, Moulay H. Alaoui Ismaili, Lawren C. Wu, Nico Ghilardi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/c1b21708fc0a4c58b4c58242d9d32c50
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c1b21708fc0a4c58b4c58242d9d32c50
record_format dspace
spelling oai:doaj.org-article:c1b21708fc0a4c58b4c58242d9d32c502021-12-02T15:34:46ZNF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus10.1038/s41467-017-02672-02041-1723https://doaj.org/article/c1b21708fc0a4c58b4c58242d9d32c502018-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-02672-0https://doaj.org/toc/2041-1723Clinical trials of BAFF blockade with belimumab have shown partial efficacy for the treatment of systemic lupus erythematosus (SLE), so other therapeutic options are required. Here, the authors present a new small molecule inhibitor that targets NIK with a similar efficacy to BAFF inhibition in two mouse models of SLE.Hans D. BrightbillEric SutoNicole BlaquiereNandhini RamamoorthiSwathi Sujatha-BhaskarEmily B. GogolGeorgette M. CastanedoBenjamin T. JacksonYoungsu C. KwonSusan HallerJustin LeschKarin BentsChristine EverettPawan Bir KohliSandra LingeLaura ChristianKathy BarrettAllan JaochicoLeonid M. BerezhkovskiyPeter W. FanZora ModrusanKelli VelizMichael J. TownsendJason DeVossAdam R. JohnsonRobert GodemannWyne P. LeeCary D. AustinBrent S. McKenzieJason A. HackneyJames J. CrawfordSteven T. StabenMoulay H. Alaoui IsmailiLawren C. WuNico GhilardiNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Hans D. Brightbill
Eric Suto
Nicole Blaquiere
Nandhini Ramamoorthi
Swathi Sujatha-Bhaskar
Emily B. Gogol
Georgette M. Castanedo
Benjamin T. Jackson
Youngsu C. Kwon
Susan Haller
Justin Lesch
Karin Bents
Christine Everett
Pawan Bir Kohli
Sandra Linge
Laura Christian
Kathy Barrett
Allan Jaochico
Leonid M. Berezhkovskiy
Peter W. Fan
Zora Modrusan
Kelli Veliz
Michael J. Townsend
Jason DeVoss
Adam R. Johnson
Robert Godemann
Wyne P. Lee
Cary D. Austin
Brent S. McKenzie
Jason A. Hackney
James J. Crawford
Steven T. Staben
Moulay H. Alaoui Ismaili
Lawren C. Wu
Nico Ghilardi
NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
description Clinical trials of BAFF blockade with belimumab have shown partial efficacy for the treatment of systemic lupus erythematosus (SLE), so other therapeutic options are required. Here, the authors present a new small molecule inhibitor that targets NIK with a similar efficacy to BAFF inhibition in two mouse models of SLE.
format article
author Hans D. Brightbill
Eric Suto
Nicole Blaquiere
Nandhini Ramamoorthi
Swathi Sujatha-Bhaskar
Emily B. Gogol
Georgette M. Castanedo
Benjamin T. Jackson
Youngsu C. Kwon
Susan Haller
Justin Lesch
Karin Bents
Christine Everett
Pawan Bir Kohli
Sandra Linge
Laura Christian
Kathy Barrett
Allan Jaochico
Leonid M. Berezhkovskiy
Peter W. Fan
Zora Modrusan
Kelli Veliz
Michael J. Townsend
Jason DeVoss
Adam R. Johnson
Robert Godemann
Wyne P. Lee
Cary D. Austin
Brent S. McKenzie
Jason A. Hackney
James J. Crawford
Steven T. Staben
Moulay H. Alaoui Ismaili
Lawren C. Wu
Nico Ghilardi
author_facet Hans D. Brightbill
Eric Suto
Nicole Blaquiere
Nandhini Ramamoorthi
Swathi Sujatha-Bhaskar
Emily B. Gogol
Georgette M. Castanedo
Benjamin T. Jackson
Youngsu C. Kwon
Susan Haller
Justin Lesch
Karin Bents
Christine Everett
Pawan Bir Kohli
Sandra Linge
Laura Christian
Kathy Barrett
Allan Jaochico
Leonid M. Berezhkovskiy
Peter W. Fan
Zora Modrusan
Kelli Veliz
Michael J. Townsend
Jason DeVoss
Adam R. Johnson
Robert Godemann
Wyne P. Lee
Cary D. Austin
Brent S. McKenzie
Jason A. Hackney
James J. Crawford
Steven T. Staben
Moulay H. Alaoui Ismaili
Lawren C. Wu
Nico Ghilardi
author_sort Hans D. Brightbill
title NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
title_short NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
title_full NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
title_fullStr NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
title_full_unstemmed NF-κB inducing kinase is a therapeutic target for systemic lupus erythematosus
title_sort nf-κb inducing kinase is a therapeutic target for systemic lupus erythematosus
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/c1b21708fc0a4c58b4c58242d9d32c50
work_keys_str_mv AT hansdbrightbill nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT ericsuto nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT nicoleblaquiere nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT nandhiniramamoorthi nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT swathisujathabhaskar nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT emilybgogol nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT georgettemcastanedo nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT benjamintjackson nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT youngsuckwon nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT susanhaller nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT justinlesch nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT karinbents nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT christineeverett nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT pawanbirkohli nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT sandralinge nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT laurachristian nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT kathybarrett nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT allanjaochico nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT leonidmberezhkovskiy nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT peterwfan nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT zoramodrusan nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT kelliveliz nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT michaeljtownsend nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT jasondevoss nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT adamrjohnson nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT robertgodemann nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT wyneplee nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT carydaustin nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT brentsmckenzie nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT jasonahackney nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT jamesjcrawford nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT steventstaben nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT moulayhalaouiismaili nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT lawrencwu nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
AT nicoghilardi nfkbinducingkinaseisatherapeutictargetforsystemiclupuserythematosus
_version_ 1718386742523854848